CA
NZ
UK
AU
IND
US
Catalyst Pharmaceuticals closed its merger with Angelini Pharma's subsidiary, cancelling every outstanding share and delivering a cash payment. The transaction turned the company into a wholly owned subsidiary of Angelini Pharma, ending its independent existence on the Nasdaq Capital Market. The move follows a …
Chicago Atlantic Real Estate Finance (NASDAQ: REFI) is set to combine with Chicago Atlantic BDC through an all‑stock arrangement that will produce a single platform with a projected net asset value of $613 million. Both boards have given their unanimous consent, and the exchange …
The deal, which received unanimous approval from both companies’ boards, represents one of the most significant biopharmaceutical mergers of the year. After accounting for Crinetics’ existing cash position, the net value reflects a substantial premium compared to earlier analyst expectations. Crinetics’ stock has seen …
Eli Lilly and Co. (NYSE: LLY) is expanding into psychedelics with a $2.8 billion acquisition of AtaiBeckley, a developer of experimental mental health treatments. The deal, announced Wednesday, gives Lilly access to DMT and MDMA-based drugs as the pharmaceutical giant builds on a quarter …
First Hawaiian (NASDAQ: FHB) has agreed to acquire TriCo Bancshares in an all‑stock merger, marking its largest expansion into California’s banking market. The deal values TriCo shareholders at 2.095 shares of FHB common stock for each share they hold, with a par value of …
Dana Inc. is expanding its auto parts empire with a blockbuster merger that sent its stock up 1.4% to $27.45 in recent trading. The company’s $2.6 billion bridge loan, arranged with Goldman Sachs, will finance a $1.1 billion cash payment to Eaton as part …
Nuvalent has been acquired by GlaxoSmithKline in an all-cash transaction valued at $10.6 billion. The deal, which closed on July 15, 2026, priced each share at $124, marking a definitive end to the company’s public trading status. The acquisition was structured as a tender …
Senti Biosciences has entered into an agreement to merge a significant portion of its assets with an entity affiliated with Celadon Partners, its largest shareholder. Following the transaction, Senti will continue as a publicly traded company with a narrower focus on select technology and …
A $53 billion takeover bid for PayPal by payments giant Stripe and private equity firm Advent International sent shares of the digital payments leader soaring, reshaping the competitive environment for fintech mergers. The offer, valuing PayPal at $60.50 per share, arrives as the company …
Under the terms disclosed, Stripe and Advent are offering $60.50 for each PayPal share, representing a 28% premium to the stock's closing price on Tuesday. Premiums of this size are typically necessary in take-private and strategic acquisition scenarios to secure target shareholder support, and …
Please wait processing your request...